(13-304) Feasibility of Extending Urine Protein Monitoring Frequency for Patients on Bevacizumab

Wednesday, December 10, 2025

3:15 PM - 4:15 PM

Location: Bayside A, Level 1

Residency Program: Providence Holy Family Hospital
Residency Program Type: PGY1 (Pharmacy)
Residency Program Location: Washington

Primary Author(s)

Amanda Whitehead, Doctor of Pharmacy

PGY1 Pharmacy Resident
Providence Holy Family Hospital